# An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)

> **NCT06556056** · NA · COMPLETED · sponsor: **NovoBliss Research Pvt Ltd** · enrollment: 108 (actual)

## Conditions studied

- Androgenic Alopecia

## Interventions

- **OTHER:** SesZen-Bio Serum
- **OTHER:** Minoxidil hair serum (1%)
- **OTHER:** Placebo
- **OTHER:** Liposomal Form of SesZenBio
- **OTHER:** Minoxidil Hair Serum (5%)
- **OTHER:** SesZen-Bio Serum + SesZen-Bio 350 mg extract

## Key facts

- **NCT ID:** NCT06556056
- **Lead sponsor:** NovoBliss Research Pvt Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556056, "An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06556056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*